美瑞健康國際產業集團有限公司（港交所代码：02327）于2026年1月12日公布翌日披露报表，披露公司于当日进行股份回购，数量为3,762,000股，占回购前已发行股份约0.09%。本次回购价格介乎每股港币0.265元至0.285元，合计支付约港币1,024,650元。
本次回购后，公司已发行股份数由4,093,756,636股降至4,089,994,636股，并形成3,762,000股库藏股。根据公告显示，公司原于2025年6月27日获股东会通过回购授权，可回购最多409,375,663股股份。截至目前，公司已累计回购36,834,000股，占授权数约9%。
公告亦显示，公司确认已遵守香港联交所相关上市规则及法定程序。本次公告由联席公司秘书蔡贵昆签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.